These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38916169)

  • 41. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
    Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
    JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central nervous system vasculitis in VEXAS syndrome: A rare involvemen.
    Langlois V; Curie A; Demas A; Etancelin P; Sauvètre G; Leclancher A; Mekinian A
    Clin Neurol Neurosurg; 2024 Jul; 242():108351. PubMed ID: 38801808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome.
    Stiburkova B; Pavelcova K; Belickova M; Magaziner SJ; Collins JC; Werner A; Beck DB; Balajkova V; Salek C; Vostry M; Mann H; Vencovsky J
    Arthritis Rheumatol; 2023 Jul; 75(7):1285-1290. PubMed ID: 36762418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.
    Ferrada MA; Savic S; Cardona DO; Collins JC; Alessi H; Gutierrez-Rodrigues F; Kumar DBU; Wilson L; Goodspeed W; Topilow JS; Paik JJ; Poulter JA; Kermani TA; Koster MJ; Warrington KJ; Cargo C; Tattersall RS; Duncan CJA; Cantor A; Hoffmann P; Payne EM; Bonnekoh H; Krause K; Cowen EW; Calvo KR; Patel BA; Ombrello AK; Kastner DL; Young NS; Werner A; Grayson PC; Beck DB
    Blood; 2022 Sep; 140(13):1496-1506. PubMed ID: 35793467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Challenges of Emerging Acquired Autoinflammatory Diseases, Including VEXAS Syndrome.
    Kirino Y
    Intern Med; 2024 Feb; ():. PubMed ID: 38296470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome.
    Zakine E; Schell B; Battistella M; Vignon-Pennamen MD; Chasset F; Mahévas T; Cordoliani F; Adès L; Sébert M; Delaleu J; Jachiet M; Lepelletier C; Lemaire P; Chauvel C; Dhouaieb B; Kim R; Cassius C; Georgin-Lavialle S; Mekinian A; Bagot M; Braun T; Rousset L; Begon E; de Masson A; Fenaux P; Clappier E; Bouaziz JD
    JAMA Dermatol; 2021 Nov; 157(11):1349-1354. PubMed ID: 34495287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review.
    Kouranloo K; Ashley A; Zhao SS; Dey M
    Rheumatol Int; 2023 Jun; 43(6):1023-1032. PubMed ID: 36617363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: fevers, myalgia, arthralgia, auricular chondritis, and erythema nodosum.
    Dehghan N; Marcon KM; Sedlic T; Beck DB; Dutz JP; Chen LYC
    Lancet; 2021 Aug; 398(10300):621. PubMed ID: 34391501
    [No Abstract]   [Full Text] [Related]  

  • 49. Aortitis PET Imaging in VEXAS Syndrome: A Case Report.
    Grambow-Velilla J; Braun T; Pop G; Louzoun A; Soussan M
    Clin Nucl Med; 2023 Feb; 48(2):e67-e68. PubMed ID: 36607374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report.
    Loschi M; Roux C; Sudaka I; Ferrero-Vacher C; Marceau-Renaut A; Duployez N; Passeron T; Cluzeau T
    Bone Marrow Transplant; 2022 Feb; 57(2):315-318. PubMed ID: 34999727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Shared and distinct mechanisms of UBA1 inactivation across different diseases.
    Collins JC; Magaziner SJ; English M; Hassan B; Chen X; Balanda N; Anderson M; Lam A; Fernandez-Pol S; Kwong B; Greenberg PL; Terrier B; Likhite ME; Kosmider O; Wang Y; Samara NL; Walters KJ; Beck DB; Werner A
    EMBO J; 2024 May; 43(10):1919-1946. PubMed ID: 38360993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atypical splice-site mutations causing VEXAS syndrome.
    Templé M; Duroyon E; Croizier C; Rossignol J; Huet T; Friedrich C; Zalmai L; Priollet P; Hayem G; Tournillhac O; Le Guenno G; Hermine O; Terrier B; Kosmider O
    Rheumatology (Oxford); 2021 Dec; 60(12):e435-e437. PubMed ID: 34213531
    [No Abstract]   [Full Text] [Related]  

  • 53. VEXAS Syndrome-Review.
    Zhang Y; Dong X; Wang H
    Glob Med Genet; 2023 Sep; 10(3):133-143. PubMed ID: 37501758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome.
    Staels F; Betrains A; Woei-A-Jin FJSH; Boeckx N; Beckers M; Bervoets A; Willemsen M; Neerinckx B; Humblet-Baron S; Blockmans DE; Vanderschueren S; Schrijvers R
    Front Immunol; 2021; 12():678927. PubMed ID: 34046042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
    Georgin-Lavialle S; Terrier B; Guedon AF; Heiblig M; Comont T; Lazaro E; Lacombe V; Terriou L; Ardois S; Bouaziz JD; Mathian A; Le Guenno G; Aouba A; Outh R; Meyer A; Roux-Sauvat M; Ebbo M; Zhao LP; Bigot A; Jamilloux Y; Guillotin V; Flamarion E; Henneton P; Vial G; Jachiet V; Rossignol J; Vinzio S; Weitten T; Vinit J; Deligny C; Humbert S; Samson M; Magy-Bertrand N; Moulinet T; Bourguiba R; Hanslik T; Bachmeyer C; Sebert M; Kostine M; Bienvenu B; Biscay P; Liozon E; Sailler L; Chasset F; Audemard-Verger A; Duroyon E; Sarrabay G; Borlot F; Dieval C; Cluzeau T; Marianetti P; Lobbes H; Boursier G; Gerfaud-Valentin M; Jeannel J; Servettaz A; Audia S; Larue M; Henriot B; Faucher B; Graveleau J; de Sainte Marie B; Galland J; Bouillet L; Arnaud C; Ades L; Carrat F; Hirsch P; Fenaux P; Fain O; Sujobert P; Kosmider O; Mekinian A; ;
    Br J Dermatol; 2022 Mar; 186(3):564-574. PubMed ID: 34632574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis.
    Muratore F; Marvisi C; Castrignanò P; Nicoli D; Farnetti E; Bonanno O; Longo R; Zaldini P; Galli E; Balanda N; Beck DB; Grayson PC; Pipitone N; Boiardi L; Salvarani C
    Arthritis Rheumatol; 2022 Apr; 74(4):665-670. PubMed ID: 34611997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience.
    Diarra A; Duployez N; Fournier E; Preudhomme C; Coiteux V; Magro L; Quesnel B; Heiblig M; Sujobert P; Barraco F; Balsat M; Scanvion Q; Hachulla E; Launay D; Yakoub-Agha I; Terriou L
    Blood Adv; 2022 Feb; 6(3):998-1003. PubMed ID: 34714914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroid reduction-resistant pulmonary involvement with Sweet's syndrome suspected of being vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: A case report.
    Amakusa Y; Suzuki T; Takemura M; Oguri T
    Respirol Case Rep; 2024 Feb; 12(2):e01288. PubMed ID: 38384745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninflammatory extrafacial edema as a clue to the diagnosis of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome.
    Diaz MJ; Liu VY; Motaparthi K
    JAAD Case Rep; 2024 May; 47():96-98. PubMed ID: 38689864
    [No Abstract]   [Full Text] [Related]  

  • 60. VEXAS syndrome.
    Nakajima H; Kunimoto H
    Int J Hematol; 2024 May; ():. PubMed ID: 38819628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.